Imagine a CNS Clinical Trial That Converges Data, Technology, and Patient Science

Imagine a CNS Clinical Trial That Converges Data, Technology, and Patient Science

Research studies for central nervous system (CNS) conditions like ADHD, autism, Alzheimer’s disease, depression, Parkinson’s disease, multiple sclerosis, and schizophrenia can vary widely. With neurological, psychological, and general health considerations, CNS clinical trial requirements can cover a wide range of data needs and present unique challenges for patients, research sites, study teams, and other stakeholders.

At Clinical ink, our platform goes beyond electronic data collection to include eCOA, ePRO, eConsent, as well as cognitive, mobility, and voice assessments using mobile, wearables, and sensor technology. Clinical ink works with a variety of CNS questionnaires and assessments, including:

  • ADAS-COG
  • ADCS-ADL
  • AIMS
  • BARS
  • CDR
  • C-SSRS
  • HAM
  • Hoehn and Yahr
  • K-SADS
  • MADRS
  • MMSE
  • PANSS
  • SAS
  • UPDRS

Our platform was built for patient science, and is configurable for CNS study sites and stakeholders to efficiently manage clinical trial data. It enables:

  • Focused and valuable site interactions
  • Complex constructions and scoring, and multimedia sources for CNS studies
  • Large enrollment volumes and quick enrollment capabilities
  • Optimized review of specialized document, audio, image, and video capture
Scroll to Top